Innovation is assumed to be a good thing in health care, just as it is elsewhere, and to be crucial to the availability of greater choices for consumers. But what is it? Very little definition is provided when the term is used. This report discusses the following aspects of biotech innovation: innovation in medicinal products, innovation in manufacturing processes, and innovation in regulatory science (both oversight and licensure).
No takes yet. Share an insight, caveat, or question.
Gillian R. Woollett (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: